Immune System News and Research

RSS

GSA commends '2010 Dietary Guidelines for Americans'

The Gerontological Society of America (GSA) - the nation's largest interdisciplinary organization devoted to the field of aging - commends the federal government's recent release of the "2010 Dietary Guidelines for Americans" and particularly applauds its inclusion of specific advice for older adults.

4 Feb 2011

Method to comprehensively characterize human embryonic stem cell lines and iPS cell lines

Ever since researchers devised a recipe for turning adult cells into cells that look and act like embryonic stem cells, there has been lingering doubt in the field about just how close to embryonic stem cells each of those cell lines really is at a molecular and functional level. Now, researchers reporting in the February 4th issue of the journal Cell, a Cell Press publication, have developed a systematic way to lay those doubts about quality to rest.

4 Feb 2011

How body's first line of defence distinguishes between microbes and own structures

This week, the highly-respected US Academy of Sciences journal (PNAS) published an article describing how the first line of defence of the human immune system distinguishes between microbes and the body's own structures.

4 Feb 2011

Researchers identify regulatory defect that drives lupus

Researchers at Dana-Farber Cancer Institute in Cambridge, Mass., in collaboration with Jackson Laboratory scientists, have identified a regulatory defect that drives lupus.

4 Feb 2011

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, the most common complication of HSCT is graft-versus-host disease (GVHD), a serious and often deadly post-transplant complication that occurs when the newly transplanted donor cells recognize the recipient's own cells as foreign and react by attacking the cells in the patient's body.

4 Feb 2011

AHF urges all AIDS drug manufacturers to reduce medication cost by 20%

As part of its ongoing advocacy to lower drug prices and increase access to lifesaving medications AIDS Healthcare Foundation, the largest global AIDS organization, today urged all AIDS drug manufacturers to reduce the cost of their medications by 20% for cash-strapped state.

4 Feb 2011

Cell signaling hormone boosts immune response to clear HIV-like infection

Australian scientists have successfully cleared a HIV-like infection from mice by boosting the function of cells vital to the immune response.

4 Feb 2011

U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine

Generex Biotechnology Corporation, together with its wholly-owned immunotherapeutic vaccines subsidiary, Antigen Express, announced today that Antigen Express has received a Notice of Allowance from the United States Patent Office relating to an application making augmentative pharmaceutical composition claims for the Antigen Express AE37 immunotherapeutic cancer vaccine.

4 Feb 2011

JDRF, Eli Lilly sign agreement to fund type 1 diabetes research for re-generative medicine

Eli Lilly and Company and the Juvenile Diabetes Research Foundation today announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease.

4 Feb 2011

Immune protein exacerbates skin cancer due to sun exposure: Study

An unexpected immune protein exacerbates cancer due to sun exposure, report researchers in the January 27th issue of Nature. The study suggests that drugs blocking the protein might halt tumor growth in skin cancer patients.

3 Feb 2011

IDF commends Florida council for recommending SCID screening for all newborns

The Florida Genetics and Newborn Screening Program Advisory Council voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) – commonly known as bubble boy disease.

3 Feb 2011

Intermittent use of preventive malaria drugs in children found to help prevent malaria transmission, studies say

Three studies published on Tuesday in PLoS Medicine show that "intermittent use of preventive antimalarial drugs can be beneficial in curbing the spread of the disease in children," Agence France-Presse reports (2/1).

3 Feb 2011

ImmunoCellular Therapeutics initiates enrollment in ICT-107 Phase II trial for GBM

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, announced today that the first patient has been enrolled in its Phase II trial of ICT-107 at the New Jersey Neuroscience Institute at JFK Medical Center. ICT-107 is the company's dendritic cell based cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM).

3 Feb 2011

Vegetarians, vegans need to increase omega-3 fatty acids and vitamin B12 to reduce heart disease risk

People who follow a vegan lifestyle - strict vegetarians who try to eat no meat or animal products of any kind - may increase their risk of developing blood clots and atherosclerosis or "hardening of the arteries," which are conditions that can lead to heart attacks and stroke. That's the conclusion of a review of dozens of articles published on the biochemistry of vegetarianism during the past 30 years.

3 Feb 2011

EGEN receives 4-year, $1.6M FDA grant for EGEN-001 Phase II clinical study in ovarian cancer

EGEN, Inc. today announced that the Food and Drug Administration (FDA) has awarded the company a four-year grant of $1,600,000 to assist in the Phase II clinical development of EGEN-001, the company's lead product. EGEN-001 is under clinical development for the treatment of advanced recurrent ovarian cancer.

2 Feb 2011

Researchers discover potential vaccine capable of reducing H. pylori colonization

A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori -- a known cause of gastritis, ulcer disease and cancer.

2 Feb 2011

Study finds recurrences of shingles prevalent in the immunocompetent population

For decades, medical wisdom about shingles has been that it's a once-in-a-lifetime experience. The commonly-held belief is that patients are protected from a recurrence of the herpes zoster virus, which causes shingles, after one episode. But according to a study published in the February issue of Mayo Clinic Proceedings, recurrences of shingles may be significantly more common than doctors have suspected.

2 Feb 2011

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper in the journal Human Vaccines detailing potent immune responses in a preclinical study of Inovio's SynCon DNA vaccine for prostate cancer targeting two antigens.

2 Feb 2011

Nitrate boosts efficiency of mitochondria

The spinach-eating cartoon character Popeye has much to teach us, new research from the Swedish medical university Karolinska Institutet shows. The muscles' cellular power plants - the mitochondria - are boosted by nitrate, a substance found in abundance in vegetables such as lettuce, spinach and beetroot.

2 Feb 2011

FDA issues reminder about safe use of non-sterile alcohol prep pads

Following a recent recall of potentially contaminated non-sterile alcohol prep pads, the U.S. Food and Drug Administration today reminded health care professionals about the safe use of non-sterile alcohol prep pads to clean and disinfect the surface of the skin.

2 Feb 2011

Immune System News and Research

GSA commends '2010 Dietary Guidelines for Americans'

Method to comprehensively characterize human embryonic stem cell lines and iPS cell lines

How body's first line of defence distinguishes between microbes and own structures

Researchers identify regulatory defect that drives lupus

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

AHF urges all AIDS drug manufacturers to reduce medication cost by 20%

Cell signaling hormone boosts immune response to clear HIV-like infection

U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine

JDRF, Eli Lilly sign agreement to fund type 1 diabetes research for re-generative medicine

Immune protein exacerbates skin cancer due to sun exposure: Study

IDF commends Florida council for recommending SCID screening for all newborns

Intermittent use of preventive malaria drugs in children found to help prevent malaria transmission, studies say

ImmunoCellular Therapeutics initiates enrollment in ICT-107 Phase II trial for GBM

Vegetarians, vegans need to increase omega-3 fatty acids and vitamin B12 to reduce heart disease risk

EGEN receives 4-year, $1.6M FDA grant for EGEN-001 Phase II clinical study in ovarian cancer

Researchers discover potential vaccine capable of reducing H. pylori colonization

Study finds recurrences of shingles prevalent in the immunocompetent population

Inovio publishes scientific paper detailing SynCon DNA vaccine preclinical study for prostate cancer

Nitrate boosts efficiency of mitochondria

FDA issues reminder about safe use of non-sterile alcohol prep pads

Immunology eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News